Clinical Trial Update: Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of long-acting levodopa on obstructive sleep apnea in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea
• Parkinson Disease

Drugs mentioned

• long-acting levodopa (levodopa)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Parkinson's Disease, Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED